Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03737604 · ClinicalTrials.gov registry record · Phase 4

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

A Phase 4 study of Pain, Postoperative and Transplant;Failure,Kidney, sponsored by University of California, Davis.

Recruiting
Registry status
Phase 4
Development phase
200
Enrollment target
1
Study location

NCT03737604 is a Phase 4 study of Pain, Postoperative and Transplant;Failure,Kidney that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 200 participants, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03737604, a Phase 4 study of Pain, Postoperative and Transplant;Failure,Kidney, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

Interventions

  • DRUG Ropivacaine Continuous Infusion Catheter
  • DRUG Single Dose Liposomal Bupivicaine

Study Locations (1)

California

  • University of California Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2018-10-04
Est. Completion 2026-06-12
Phase Phase 4

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03737604

The ClinicalTrials.gov registry entry for NCT03737604 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (26% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine Continuous Infusion Catheter is the first listed.

NCT03737604 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03737604 about?

NCT03737604 is a clinical study titled "TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant". This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

What is the current status of trial NCT03737604?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2018-10-04. Estimated completion is 2026-06-12.

What conditions does trial NCT03737604 study?

This clinical trial studies the following conditions: Pain, Postoperative, Transplant;Failure,Kidney.

What interventions are being tested in trial NCT03737604?

The interventions under investigation include: Ropivacaine Continuous Infusion Catheter (DRUG), Single Dose Liposomal Bupivicaine (DRUG).

Who is sponsoring clinical trial NCT03737604?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03737604 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.